Skip to content
    GMRS
    Earnings call· Mar 2026(Q1 FY26)

    GMR Solutions Q1 FY26 earnings call GMRS

    Jun 2, 2026 Source

    Executive summary

    GMR Solutions Q1 FY26 — Strong Revenue and EBITDA Growth Driven by Emergent Services and Operational Efficiency

    GMR Solutions delivered robust Q1 FY26 results, showcasing strong revenue and adjusted EBITDA growth, primarily fueled by increased emergent transports and enhanced operational efficiency. The company successfully navigated its post-IPO financial restructuring, significantly reducing financing costs, while strategically expanding its innovative 911 Nurse Navigation program. Management remains confident in its full-year outlook despite anticipated payer mix shifts and rising fuel costs.

    Highlights

    5
    • Q1 revenues reached $1.46 billion, marking a 6.6% year-over-year growth, reflecting strong demand for mission-critical services.

    • Adjusted EBITDA grew 9.7% year-over-year to $305 million, with EBITDA margin expanding by 59 basis points to 20.9%.

    • Net income increased 179.9% to $106.3 million, driven by strong operational performance and reduced interest expense.

    • Successfully reduced annualized financing costs by over $125 million through debt reduction and preferred equity redemption post-IPO.

    • 911 Nurse Navigation solution expanded to 29 communities, with 13 more in implementation, leading to a 47% increase in navigated calls and a 15% reduction in dry runs.

    Concerns

    4
    • The proposed CMS rule on state-directed payments could result in a less than $5 million negative annual impact to GMR.

    • Expected degradation in payer mix by volume due to the One Big Beautiful Bill Act and ACA exchange subsidy elimination, impacting guidance by $25 million to $30 million for the remaining 9 months of FY26.

    • Increased fuel costs due to the Iran conflict added approximately $3 million to expenses in March and are factored into higher full-year guidance.

    • Insurance expense increased by $9.3 million or 27.6% due to higher professional liability claims and third-party premiums.

    Guidance & targets

    9
    CategoryTargetConfidence
    Full-year 2026 Revenue
    $5.89 billion to $6.18 billion
    high materiality
    High
    Full-year 2026 Adjusted EBITDA
    $1.135 billion to $1.195 billion
    high materiality
    High
    Full-year 2026 Cash used for CapEx and aircraft financing as % of total revenue
    5.1% and 5.3%
    medium materiality
    High
    Long-term Top-line Revenue Growth
    mid-single-digit plus
    high materiality
    High
    Long-term Adjusted EBITDA Growth
    high single-digit plus
    high materiality
    High
    Long-term Adjusted EBITDA Margins
    around 20%
    high materiality
    High
    Long-term Cash for CapEx and aircraft financing as % of revenue
    just above 5%
    medium materiality
    High
    Net Leverage
    below 3.3x
    high materiality
    High
    Net Leverage
    3.0x
    high materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Ground Medical Services
    Includes transports and 911 Nurse Navigation calls. Emergent ground services showed growth, while lower-reimbursing non-emergent and wheelchair transports significantly decreased, aligning with the focus on core emergent services.
    Patients: 1.3 millionTransports: 1 million911 Nurse Navigation calls: 28,000Same market emergent ground growth: 0.5%Patient encounters not resulting in transport decrease: 0.8%Lower reimbursing non-emergent patient encounters decrease: 7.2%Wheelchair patient encounters decrease: 52.8%
    Air Medical Services
    Emergent flights demonstrated growth, supported by a lower weather cancellation rate and improved capture rate, despite a slight decrease in overall emergent air requests.
    Patients: 34,000Same market emergent flights growth: 1.9%Weather cancellation rate: 17.1%Weather cancellation rate decrease YoY: 81 bpsWeather cancellation rate decrease vs 3-year average: 220 bpsOverall emergent air requests decrease: 0.8%Capture rate: 45.1%Capture rate increase: 87 bps

    Operational metrics

    48
    Adjusted EBITDA
    $305 million9.7% YoY
    Q1 2026

    Year-over-year improvement.

    Adjusted EBITDA Margin
    20.9%59 bps YoY
    Q1 2026

    Increase versus the prior year quarter.

    Cash CapEx and aircraft financing as % of total revenue
    5.4%vs 4.7% in Q1 2025
    Q1 2026

    Increase primarily driven by timing of CapEx purchases.

    Total Patient Encounters
    1.4 million
    Q1 2026

    Total patient encounters during the quarter.

    Emergent Transports (total)
    0.7%YoY
    Q1 2026

    Increase in total emergent transports.

    911 Nurse Navigation Calls
    28,000nearly 47% increase YoY
    Q1 2026

    Calls navigated through the 911 Nurse Navigation offer.

    911 Nurse Navigation Communities
    29
    Q1 2026

    Number of communities currently served by 911 Nurse Navigation.

    Dry Runs Reduction (911 Nurse Navigation)
    15%
    Q1 2026

    Average reduction in dry runs in historical 911 markets with Nurse Navigation.

    Total Transports Reduction (911 Nurse Navigation)
    2.5%
    Q1 2026

    Reduction in total transports that would likely receive little to no reimbursement.

    Total Crew Wages Increase
    3.0%YoY
    Q1 2026

    Increase predominantly tied to wage increases and filling open positions.

    Base Unit Cost per payroll hour
    3.8%YoY
    Q1 2026

    Reflects year-over-year inflation in base wages.

    Crew Vacancy Rate
    77 bpsdeclined
    Q1 2026

    Decline due to positive hiring.

    New Market Growth Revenue
    $20 million
    Q1 2026

    Revenue included from new market growth.

    New Agreements Annualized Revenue
    $47 million
    Q1 2026

    Incremental annualized revenue from new agreements executed in the quarter.

    Emergent Air Volumes
    1.1%YoY
    Q1 2026

    Increase compared to the same quarter in 2025.

    Emergent Ground Transports
    0.6%YoY
    Q1 2026

    Increase compared to the same quarter in 2025.

    Non-Emergent Ground Transports
    7.2%down YoY
    Q1 2026

    Decrease compared to the same quarter in 2025.

    Overall Emergent Air Requests
    0.8%decreased
    Q1 2026

    Slight decrease, but flights impacted by favorable weather.

    Air Capture Rate
    45.1%increased 87 bps
    Q1 2026

    Increase due to favorable weather.

    Revenue Impact from Favorable Weather
    $11 million
    Q1 2026

    Estimated impact compared to the prior year quarter.

    Net Revenue per Transport
    7.9%YoY
    Q1 2026

    Increase driven by positive mix shift and strong underlying NRT improvements.

    IDR-related Collections (2022-2024 dates of service)
    $7 milliondecrease of nearly $24 million YoY
    Q1 2026

    Collections from older dates of service, reflecting a decrease compared to prior year.

    California State Surprise Medical Billing Collections (2024 dates of service)
    $16 million
    Q1 2026

    Benefit from collections related to the implementation of California's state surprise medical billing legislation.

    Days Sales Outstanding (DSO)
    76 daysdecreased 3 days from 79 days YoY
    Q1 2026

    Decrease in DSO compared to the same quarter last year.

    IDR Win Rate
    over 90%
    Q1 2026

    Rate at which GMR wins IDR disputes.

    Commercial Air Transports In-Network
    nearly 70%
    Q1 2026

    Percentage of commercial air transports that are in-network.

    Complementary Revenue Decrease
    1.2%
    Q1 2026

    Decrease of roughly $0.5 million, primarily due to a small FEMA deployment last year.

    Complementary Revenue Growth (ex-FEMA)
    4.7%
    Q1 2026

    Growth excluding the impact of a FEMA deployment.

    Total Operating Expense
    $1.24 billionincreased 4.1% YoY
    Q1 2026

    Compared to $1.19 billion for the same period in 2025.

    Employee Wages, Benefits and Taxes
    $770 millionincreased 4.8% YoY
    Q1 2026

    Increase compared to the prior year.

    Maintenance, Fuel and Other Direct Expenses
    $119 millionincreased 6.1% YoY
    Q1 2026

    Increase primarily driven by fuel and timing of medical supplies purchases.

    Insurance Expense
    $43 millionincreased $9.3 million or 27.6% YoY
    Q1 2026

    Driven primarily by increased professional liability-related claims and third-party premium expenses.

    Other Operating Expenses
    $228.1 millionincreased 5.7% YoY
    Q1 2026

    Includes outside services and general and administrative expenses.

    Outside Services
    $1.3 millionincreased 3.1% YoY
    Q1 2026

    Increase in outside services.

    General and Administrative Expenses
    $11.0 millionincreased 6.3% YoY
    Q1 2026

    Primarily driven by increased system integration and enhancement expenses, software licensing and development, and freight expense.

    Interest Expense
    $83.2 milliondecreased 26.8% YoY
    Q1 2026

    Decrease as a result of refinancing completed in September 2025.

    Cash and Cash Equivalents
    $426.1 million
    Q1 2026

    Balance at the end of the first quarter.

    Undrawn ABL Capacity
    $692 million
    Q1 2026

    Cash borrowing capacity after letters of credit.

    Preferred Equity Reduction
    $250 million
    Q1 2026

    Reduction in preferred equity holdings using cash on March 6.

    Total Debt Reduction and Preferred Equity Redemption
    over $1.15 billion
    Q1 2026

    Combined reduction through IPO proceeds and cash on hand.

    Annualized Term Loan Interest Expense Reduction
    $46 million
    Q1 2026

    Reduction resulting from debt reduction and preferred equity redemption.

    Annualized Preferred Equity Dividend Accrual Reduction
    $73 million
    Q1 2026

    Reduction resulting from preferred equity redemption.

    Interest Rate Step Down (Moody's Upgrade)
    25 bps
    Q1 2026

    Triggered by Moody's credit rating upgrade.

    Annualized Interest Expense Reduction (Moody's Upgrade)
    $7.4 million
    Q1 2026

    Reduction after considering debt reductions.

    Total Annualized Financing Costs Reduction
    over $125 million
    Q1 2026

    Combined credit enhancements.

    Fuel Cost Impact (March)
    $3 million
    March 2026

    Impact from increased fuel prices due to the Iran conflict.

    Fuel Cost as % of Total Revenue
    2%
    Historical

    Historically, fuel expense is about 2% of total revenue.

    Fuel Cost as % Tied to Commodity Price
    1%
    Historical

    Approximately 1% of total revenue is tied to the commodity price of fuel.

    Industry KPIs

    5
    MetricValueDetails
    Utilization trends0.7%%
    Payer mix supplemental payments57%%
    Membership covered lives by lineover 22 millionlives
    Adjusted EPS EBITDA leverage guidance$305 millionUSD
    Prior authorization operational metrics28,000calls

    Deals & partnerships

    1
    Largest out-of-network payerCustomer contract

    Agreement signed effective February 1, 2026, bringing the largest out-of-network payer in-network at reasonable rates and terms.

    Risks & headwinds

    4
    Proposed CMS rule on state-directed paymentsAnnual

    Less than $5 million negative annual impact

    Mitigation: Evaluating potential impacts, potential for share gains from municipal providers.

    Degraded payer mix from One Big Beautiful Bill Act and ACA exchange subsidiesRemaining 9 months of FY26

    $25 million to $30 million impact

    Mitigation: Factored into guidance; closely monitoring payer mix.

    Higher fuel costs due to Iran conflictQ1 2026 and full year 2026

    $3 million impact in March; $25 million to $30 million for full year guidance

    Mitigation: Factored into guidance; considering fuel hedging as a potential option.

    Increased insurance expenseQ1 2026

    $9.3 million or 27.6% increase to $43 million

    Mitigation: Driven by increased professional liability-related claims and third-party premium expenses.

    Q&A highlights

    6

    Can you unpack the ACA attrition impact experienced in Q1, detail benefits from ACA-related volumes in 2025, and what's factored into 2026 guidance for ACA volumes?

    Management noted minimal ACA impact in Q1 but anticipates a $25M-$30M headwind for the remaining 9 months of FY26 due to payer mix degradation from the One Big Beautiful Bill Act and ACA exchange subsidy elimination, observing a 1% mix shift out of commercial in April. They clarified that 2025 did not see significant movement.

    Total exchange and One Big Beautiful Bill Act impact that's in our guidance for the year, really for the last 9 months, is in that $25 million to $30 million total range.

    asked by Benjamin Rossi · answered by Brian Tierney

    2 min read6 chapters

    Detailed Narrative

    01

    IPO and Strategic Focus

    GMR Solutions successfully completed its IPO, marking a significant milestone after refocusing on emergency care, which led to increased profitability and a strengthened financial profile. The company emphasizes its role as the 'front line of the front line' in healthcare, serving 5.5 million patients annually across over 60% of the U.S. population. This strategic shift has positioned GMR to publicly demonstrate the value of EMS as a critical healthcare service.

    02

    Operational Innovations and Expansion

    The company highlighted its innovative offerings, including 911 Nurse Navigation, Concierge Platform, and Transport.NET, designed to streamline EMS systems and improve patient care. The 911 Nurse Navigation program, which aims to reduce dry runs and inappropriate transports, expanded to 29 communities with 13 more in implementation, resulting in a 47% increase in navigated calls year-over-year and a 15% reduction in dry runs in historical markets.

    03

    Regulatory Landscape and Advocacy

    GMR is actively engaging with Congress to advocate for modernized air and ground ambulance reimbursement from CMS based on cost data. The company also discussed a proposed CMS rule on state-directed payments, which could limit Medicaid payments to 100%-110% of Medicare rates for targeted provider groups. While this rule is estimated to have a less than $5 million negative annual impact, management sees potential for market share gains from municipal providers who may face increased pressure.

    04

    Payer Mix Dynamics and Collections

    The company reported a Q1 FY26 payer mix by net transport revenue of 57% commercial, 25% Medicare, 9% Medicaid, 7% other, and 2% self-pay, showing a positive mix shift towards emergent transports. While IDR-related collections from older dates of service decreased by $24 million year-over-year, GMR benefited from $16 million in collections related to California's state surprise medical billing legislation. The company's high IDR win rate (over 90%) is leveraged in renegotiating expiring air contracts and bringing new payers in-network.

    05

    Labor and New Business Growth

    Crew staffing metrics are in line with expectations, with total crew wages up 3.0% year-over-year and a 77 basis point decline in crew vacancy rate, reflecting continued investment in staff. GMR remains optimistic about new business opportunities in core EMS, 911 Nurse Navigation expansion, and municipal ambulance contracting. The company secured $20 million in new market growth and $47 million in incremental annualized revenue from new agreements in the quarter, actively responding to RFPs for rural health transformation programs.

    06

    Capital Structure and Deleveraging

    Post-IPO, GMR significantly improved its financial position by reducing preferred equity holdings by $250 million and achieving over $1.15 billion in total debt reduction and preferred equity redemption. This restructuring resulted in a $46 million reduction in annualized term loan interest expense and a $73 million reduction in annualized preferred equity dividend accrual. Net leverage after the IPO was approximately 3.5x, with a clear target to reduce it below 3.3x by year-end 2026 and to 3.0x in 2027.

    AI-generated summary of the company’s earnings call. Not investment advice.